Bristol-Myers Squibb Company(BMY) News

Date	Title
May 30	Bristol Myers (BMY) Gets EC Nod for Opdivo Label Expansion
May 29	Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate
May 29	BMS secures another EC approval for Opdivo combination
May 29	BMS stakes $80m on Prothena’s neurodegenerative candidate
May 29	Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
May 28	ASPIRE: Our Commitment To Address Health Inequities in Low- and Middle-Income Countries
May 24	Terran Biosciences prepares for trials of schizophrenia drug
May 23	Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms
May 23	Does Bristol-Myers Squibb (NYSE:BMY) Have A Healthy Balance Sheet?
May 23	This Unpopular Dividend Stock Is a Buy
May 23	Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
May 22	Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M
May 22	Pfizer to Cut Costs in Multi-Year Effort
May 22	Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo
May 22	Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million
May 22	Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income Countries
May 22	Bristol-Myers Squibb Announces Strategies to Improve Access to Medicines
May 22	NeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb
May 22	Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit
May 18	Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 79%